Mycobacterium Citations List: October, 2015

PubMed Citations

1. Quantitative Structure-Activity Relationship of Molecules Constituent of Different Essential Oils with Antimycobacterial Activity against Mycobacterium tuberculosis and Mycobacterium bovis. Andrade-Ochoa, S., G. Nevárez-Moorillón, L. Sánchez-Torres, M. Villanueva-García, B. Sánchez-Ramírez, L. Rodríguez-Valdez, and B. Rivera-Chavira. BMC Complementary and Alternative Medicine, 2015. 15(1): p. 332. PMID[26400221]. PMC[4579641].
[PubMed]. TB_10_2015.

2. A Nano-MgO and Ionic Liquid-catalyzed 'Green' Synthesis Protocol for the Development of Adamantyl-imidazolo-thiadiazoles as Anti-tuberculosis Agents Targeting Sterol 14alpha-Demethylase (Cyp51). Anusha, S., B. Cp, C.D. Mohan, J. Mathai, S. Rangappa, S. Mohan, Chandra, S. Paricharak, L. Mervin, J.E. Fuchs, M. M, A. Bender, Basappa, and K.S. Rangappa. PlosOne, 2015. 10(10): p. e0139798. PMID[26470029].

[PubMed]. TB_10_2015.

3. Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin. Chaudhary, S., V. Sharma, P.K. Jaiswal, A.N. Gaikwad, S.K. Sinha, S.K. Puri, A. Sharon, P.R. Maulik, and V. Chaturvedi. Organic Letters, 2015. 17(20): p. 4948-4951. PMID[26430796].

[PubMed]. TB_10_2015.

4. Antimycobacterial Activities of Endolysins Derived from a Mycobacteriophage, BTCU-1. Lai, M.J., C.C. Liu, S.J. Jiang, P.C. Soo, M.H. Tu, J.J. Lee, Y.H. Chen, and K.C. Chang. Molecules, 2015. 20(10): p. 19277-19290. PMID[26506338].

[PubMed]. TB_10_2015.

5. Mycobacterium Tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds. Makowska-Grzyska, M., Y. Kim, S.K. Gorla, Y. Wei, K. Mandapati, M. Zhang, N. Maltseva, G. Modi, H.I. Boshoff, M. Gu, C. Aldrich, G.D. Cuny, L. Hedstrom, and A. Joachimiak. Plos One, 2015. 10(10): p. e0138976. PMID[26440283].

[PubMed]. TB_10_2015.

6. New Non-toxic Semi-synthetic Derivatives from Natural Diterpenes Displaying Anti-tuberculosis Activity. Matos, P.M., B. Mahoney, Y. Chan, D.P. Day, M.M. Cabral, C.H. Martins, R.A. Santos, J.K. Bastos, P.C. Page, and V.C. Heleno. Molecules, 2015. 20(10): p. 18264-18278. PMID[26457701].

[PubMed]. TB_10_2015.

7. 4-Aminoquinoline Derivatives as Novel Mycobacterium tuberculosis GYRB Inhibitors: Structural Optimization, Synthesis and Biological Evaluation. Medapi, B., P. Suryadevara, J. Renuka, J.P. Sridevi, P. Yogeeswari, and D. Sriram. European Journal of Medicinal Chemistry, 2015. 103: p. 1-16. PMID[26318054].

[PubMed]. TB_10_2015.

8. Identification and Validation of Aspartic acid semialdehyde dehydrogenase as a New anti-Mycobacterium tuberculosis Target. Meng, J., Y. Yang, C. Xiao, Y. Guan, X. Hao, Q. Deng, and Z. Lu. International Journal of Molecular Sciences. 16(10): p. 23572-23586. PMID[26437401].
[PubMed]. TB_10_2015.

9. Design, Synthesis and Evaluation of Diarylpiperazine Derivatives as Potent Anti-tubercular Agents. Penta, A., S. Franzblau, B. Wan, and S. Murugesan. European Journal of Medicinal Chemistry, 2015. 105: p. 238-244. PMID[26498570].

[PubMed]. TB_10_2015.

10. Synthesis and Biological Evaluation of Polar Functionalities Containing Nitrodihydroimidazooxazoles as anti-TB Agents. Yempalla, K.R., G. Munagala, S. Singh, G. Kour, S. Sharma, R. Chib, S. Kumar, P. Wazir, G.D. Singh, S. Raina, S.S. Bharate, I.A. Khan, R.A. Vishwakarma, and P.P. Singh. ACS Medicinal Chemistry Letters, 2015. 6(10): p. 1059-1064. PMID[26487912].

[PubMed]. TB_10_2015.

11. Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies. Yempalla, K.R., G. Munagala, S. Singh, A. Magotra, S. Kumar, V.S. Rajput, S.S. Bharate, M. Tikoo, G.D. Singh, I.A. Khan, R.A. Vishwakarma, and P.P. Singh. ACS Medicinal Chemistry Letters, 2015. 6(10): p. 1041-1046. PMID[26487909].

[PubMed]. TB_10_2015.

ISI Web of Knowledge Citations

12. Synthesis, in Vitro and in Silico Studies of Some Novel 5-Nitrofuran-2-yl hydrazones as Antimicrobial and Antitubercular Agents. Abdel-Aziz, H., W. Eldehna, M. Fares, T. Elsaman, M. Abdel-Aziz, and D. Soliman. Biological & Pharmaceutical Bulletin, 2015. 38(10): p. 1617-1630. PMID[26155871].
[WOS]. TB_10_2015.

13. Antimicrobial Activity of TiO2:Ag Nanocrystalline Heterostructures: Experimental and Theoretical Insights. Andre, R., C. Zamperini, E. Mima, V. Longo, A. Albuquerque, J. Sambrano, A. Machado, C. Vergani, A. Hernandes, J. Varela, and E. Longo. Chemical Physics, 2015. 459: p. 87-95. ISI[000361453500013].
[WOS]. TB_10_2015.

14. Development of ssDNA Aptamers as Potent Inhibitors of Mycobacterium tuberculosis Acetohydroxyacid Synthase. Baig, I.A., J.Y. Moon, S.C. Lee, S.W. Ryoo, and M.Y. Yoon. Biochimica Et Biophysica Acta-Proteins and Proteomics, 2015. 1854(10): p. 1338-1350. ISI[000362307500011].

[WOS]. TB_10_2015.

15. Combating Highly Resistant Emerging Pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with Novel Salicylanilide Esters and Carbamates. Baranyai, Z., M. Kratky, J. Vinsova, N. Szabo, Z. Senoner, K. Horvati, J. Stolarikova, S. David, and S. Bosze. European Journal of Medicinal Chemistry, 2015. 101: p. 692-704. PMID[26210507].
[WOS]. TB_10_2015.

16. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity. Chandrasekera, N., T. Alling, M. Bailey, M. Files, J. Early, J. Ollinger, Y. Ovechkina, T. Masquelin, P. Desai, J. Cramer, P. Hipskind, J. Odingo, and T. Parish. Journal of Medicinal Chemistry, 2015. 58(18): p. 7273-7285. PMID[26295286].
[WOS]. TB_10_2015.

17. The ATPase Activity of the Mycobacterial Plasma Membrane is inhibited by the LL37-analogous Peptide LLAP. Chingate, S., G. Delgado, L. Salazar, and C. Soto. Peptides, 2015. 71: p. 222-228. PMID[26218806].
[WOS]. TB_10_2015.

18. Evaluation of Substituted methyl cyclohexanone hybrids for Anti-tubercular, Anti-bacterial and Anti-fungal Activity: Facile Syntheses under Catalysis by Ionic Liquids. Ghatole, A., K. Lanjewar, M. Gaidhane, and K. Hatzade. Spectrochimica acta Part A-Molecular and Biomolecular Spectroscopy, 2015. 151: p. 515-524. PMID[26162339].
[WOS]. TB_10_2015.

19. Design, Synthesis of Quinolinyl Schiff Bases and Azetidinones as Enoyl ACP-reductase Inhibitors. Joshi, S., U. More, D. Parkale, T. Aminabhavi, A. Gadad, M. Nadagouda, and R. Jawarkar. Medicinal Chemistry Research, 2015. 24(11): p. 3892-3911. ISI[000361758000013].
[WOS]. TB_10_2015.

20. Chemical Composition and Biological Activity of Essential Oils of Sempervivum brevipilum Muirhead. Kahriman, N., Z. Senyurek, V. Serdaroglu, A. Kahriman, and N. Yayli. Records of Natural Products, 2015. 9(4): p. 603-608. ISI[000361530500020].
[WOS]. TB_10_2015.

21. Triazole: A Promising Antitubercular Agent. Keri, R., S. Patil, S. Budagumpi, and B. Nagaraja. Chemical Biology & Drug Design, 2015. 86(4): p. 410-423. PMID[25643871].
[WOS]. TB_10_2015.

22. Development of a Three Component Complex to Increase Isoniazid Efficacy against Isoniazid Resistant and Nonresistant Mycobacterium tuberculosis. Manning, T., S. Plummer, T. Baker, G. Wylie, A. Clingenpeel, and D. Phillips. Bioorganic & Medicinal Chemistry Letters, 2015. 25(20): p. 4621-4627. PMID[26341133].
[WOS]. TB_10_2015.

23. Design of Novel Dispirooxindolopyrrolidine and Dispirooxindolopyrrolothiazole Derivatives as Potential Antitubercular Agents. Mhiri, C., S. Boudriga, M. Askri, M. Knorr, D. Sriram, P. Yogeeswari, F. Nana, C. Golz, and C. Strohmann. Bioorganic & Medicinal Chemistry Letters, 2015. 25(19): p. 4308-4313. PMID[26271585].
[WOS]. TB_10_2015.

24. Permeability Enhancing Lipid-based Co-solvent and SEDDS Formulations of SQ641, an Antimycobacterial Agent. Mutyam, S., N. Bejugam, H. Parish, V. Reddy, E. Bogatcheva, and G. Shankar. Pharmaceutical Development and Technology, 2015. 20(5): p. 598-607. PMID[24946795].
[WOS]. TB_10_2015.

25. Andrographolide: A Potent Antituberculosis Compound that Targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis. Prabu, A., S. Hassan, Prabuseenivasan, A. Shainaba, L. Hanna, and V. Kumar. Journal of Molecular Graphics & Modelling, 2015. 61: p. 133-140. PMID[26245695].
[WOS]. TB_10_2015.

26. Antifolate Activity of Plant Polyphenols against Mycobacterium tuberculosis. Raju, A., M.S. Degani, M.P. Khambete, M.K. Ray, and M.G.R. Rajan. Phytotherapy Research, 2015. 29(10): p. 1646-1651. ISI[000362792900027].

[WOS]. TB_10_2015.

27. One-pot Synthesis of new Triazole-imidazo[2,1-b][1,3,4]thiadiazole hybrids via Click Chemistry and Evaluation of Their Antitubercular Activity. Ramprasad, J., N. Nayak, U. Dalimba, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2015. 25(19): p. 4169-4173. PMID[26298500].
[WOS]. TB_10_2015.

28. Design, Synthesis of Benzocoumarin-pyrimidine Hybrids as Novel Class of Antitubercular Agents, their DNA Cleavage and X-ray Studies. Reddy, D., K. Hosamani, and H. Devarajegowda. European Journal of Medicinal Chemistry, 2015. 101: p. 705-715. PMID[26210508].
[WOS]. TB_10_2015.

29. Phenylbutyrate Induces LL-37-dependent Autophagy and Intracellular Killing of Mycobacterium tuberculosis in Human Macrophages. Rekha, R., S. Muvva, M. Wan, R. Raqib, P. Bergman, S. Brighenti, G. Gudmundsson, and B. Agerberth. Autophagy, 2015. 11(9): p. 1688-1699. PMID[26218841].
[WOS]. TB_10_2015.

30. Piperazine Derivatives: Synthesis, Inhibition of the Mycobacterium tuberculosis Enoyl-acyl Carrier Protein Reductase and SAR Studies. Rotta, M., K. Pissinate, A.D. Villela, D.F. Back, L. Timmers, J.F.R. Bachega, O.N. de Souza, D.S. Santos, L.A. Basso, and P. Machado. European Journal of Medicinal Chemistry, 2014. 87: p. 436-447. ISI[000362620900036].

[WOS]. TB_10_2015.

Patent Citations

31. Inhibitors of Drug-resistant Mycobacterium tuberculosis. Bishai, W.R., S. Lun, and H. Guo. Patent. 2015. 2015-US27053 2015164482: 74pp.

[Patent]. TB_10_2015.

32. Preparation of Oxazoloquinoline Derivatives as Antibacterial Compounds. Ratcliffe, A., A. Huxley, D. Lyth, G. Noonan, R. Kirk, M. Uosis-Martin, and N. Stokes. Patent. 2015. 2015-GB51107 2015155549: 183pp.

[Patent]. TB_10_2015.